A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Clinical trial NCT05531565 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT05531565

Sponsor

Biogen

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2, Phase 3

Study type

INTERVENTIONAL

Start date

2022-09-13

Primary completion

2026-10-20

Enrollment

450

View on ClinicalTrials.gov